ARIPRA aripiprazole 10 mg tablet bottle

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

aripiprazole, Quantity: 10 mg

Disponible des:

Medis Pharma Pty Ltd

Designació comuna internacional (DCI):

aripiprazole

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: magnesium stearate; microcrystalline cellulose; hyprolose; lactose monohydrate; maize starch

Vía de administración:

Oral

Unidades en paquete:

100, 250

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

Resumen del producto:

Visual Identification: 8mm x 5 mm, capsule shaped, biconvex, white uncoated tablets with 10 debossed on one side and ZL on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Estat d'Autorització:

Licence status A

Data d'autorització:

2014-10-29